News|Videos|November 15, 2023

Investing in Science to Innovate Wellness

Author(s)Gnosis

Gnosis highlights several new product launches at SupplySide West and continues to invest in clinical validation for its branded health solutions. The company keeps its customers at the forefront, using innovation to make formulating with its validated ingredients easy while also creating ready-for-market solutions.


Related to this article

Denis Neville, CoreFX Ingredients
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Denis Neville, founder and CEO of CoreFX Ingredients, about the launch of CreaSHLD-IN.
Brian Appell Givaudan
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Brian Appell, product manager, Givaudan, about the launch of NovaBerin for the metabolic health market.
Elzaphan Hotam
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Elzaphan Hotam, director at TriNutra, about new clinical and preprint data on ThymoQuin.
Komal Baldwa, founder and CEO of aspurus
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Komal Baldwa, founder and CEO of aspurus about the company’s life-stage optimized dosing platform for women’s health.